Plasma Fractionation Market by Application (Neurology, Immunology, Hematology, Rheumatology) | Global Forecast to 2027

The global plasma fractionation market size is projected to reach USD 36.7 billion by 2027 from USD 26.5 billion in 2022, at a CAGR of 6.7% during the forecast period. Market growth is driven mainly by factors such as rapid growth of geriatric population, growing prevalence of respiratory disorders such as alpha-1-antitrypsin deficiency (AATD) and emphysema, and use of plasma fractionation products as first-line therapies for a number of bleeding, hematological, and neurological diseases. However high cost of plasma products and the lack of sufficient reimbursements, increasing adoption of on-demand recombinant factors, and shortage of plasma for manufacturing plasma fractionation products are expected to restrain the growth of this market to a certain extent during the forecast period.

Download FREE PDF of the Report @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=320632

List of Companies Profiled in the Report

CSL (Australia)
Grifols, S.A. (Spain)
Shire (US)
Octapharma AG (Switzerland)
Kedrion S.P.A (Italy)
LFB (France)
Biotest AG (Germany)
Sanquin (Netherlands)
China Biologic Products Holdings Inc. (China)
GC Pharma (Korea)
Bio Products Ltd. (UK)
Japan Blood Products Organization (Japan)
Emergent BioSolutions (US)
Shanghai Raas Blood Products Co., Ltd. (China)
Intas Pharmaceuticals Ltd. (India)
Bharat Serum Vaccines Limited (India)
SK Plasma (Korea)
Sichuan YuandaShuyang Pharmaceutical Co., Ltd. (China)
KabaFusion (US)
Centurion Pharma (Istanbul)
ADMA Biologics, Inc. (US)
PlasmaGenBioSciences Pvt. Ltd. (India)
Virchow Biotech Private Limited (India)
Fusion Healthcare (India)
Hemarus Therapeutics Limited (India)

This report provides a detailed picture of the global plasma fractionation market. It aims at estimating the size and future growth potential of the market across different segments, such as product, application, end user,and region. The report also analyzes factors (such as drivers, restraints, and opportunities) affecting the market growth. It evaluates the opportunities in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total plasma fractionation market. The report forecasts the revenue of the market segments with respect to four major regions.

Geographically, the plasma fractionation market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. In 2021, North America accounted for the largest share of the plasma fractionation market, followed by Europe and the Asia Pacific. The large share of North America in the global market is attributed to the leading players adopting various organic and inorganic growth strategies to strengthen their market positions. The expansion of fractionation plants with state-of-the-art technologies is a key growth strategy followed by major players in this market in the region. Leading players also focus on acquiring plasma collection centers to expand their presence in North America.

Get Discount on Purchase this Report @ https://www.reportsnreports.com/purchase.aspx?name=320632

Reasons to Buy the Report:

The report provides insights on the following pointers:

Market Penetration: Comprehensive information on plasma fractionation offered by the top 25 players in the plasma fractionation market. The report analyses the plasma fractionation market by product, application, end user, and region.
Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various plasma fractionation across key geographic regions.
Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the plasma fractionation market.
Competitive Assessment: In-depth assessment of market ranking and strategies of the leading players in the plasma fractionation market.

+ 1 888 391 5441
sales@reportsandreports.com

ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets.

This release was published on openPR.